Charles & Colvard stock (US1596961028): turnaround hopes after delisting and strategic review

Charles & Colvard, a US specialist in lab?grown moissanite and other gemstones, is in a restructuring phase after delisting from Nasdaq and initiating a strategic review of its business. The company reported results for the quarter ended December 31, 2024 on February 13, 2025, highlighting lower revenue but cost controls and a focus on direct?to?consumer channels, according to Charles & Colvard investor relations as of 02/13/2025.

As of: 16.05.2026

By the editorial team – specialized in equity coverage.

Charles & Colvard: core business model

Charles & Colvard focuses on designing, sourcing and selling jewelry based on lab?grown gemstones, with moissanite as a flagship product. The company offers engagement rings, wedding bands and fashion jewelry, positioning lab?created stones as an alternative to mined diamonds. It operates both direct?to?consumer and wholesale channels in the United States.

The company emphasizes ethical and environmental aspects of lab?grown stones, targeting consumers who seek transparency in sourcing. Its product portfolio spans loose stones and finished jewelry, with a wide range of cuts, sizes and metal settings. Over recent years, management has expanded beyond moissanite into other lab?grown gemstones, including sapphires and diamonds, to broaden its addressable market.

Historically, Charles & Colvard relied significantly on wholesale and distribution partners, but the shift in consumer behavior toward online shopping has prompted a strategic tilt to e?commerce. The firm operates its own web store and collaborates with online marketplaces. This business model implies relatively lower capital intensity compared to traditional jewelry retailers with large store networks, but it increases dependence on digital marketing effectiveness and logistics.

Main revenue and product drivers for Charles & Colvard

The main revenue drivers for Charles & Colvard are sales of moissanite and other lab?grown gemstones set in engagement rings and bridal jewelry. Consumer demand in the US market for non?traditional engagement stones, influenced by price sensitivity and ethical considerations, plays a central role in the company’s performance. Seasonal peaks around the holiday period and the wedding season typically affect quarterly revenue patterns.

On February 13, 2025, the company reported net sales of 4.1 million USD for its second quarter of fiscal 2025, compared with 5.2 million USD in the same quarter of the prior year, reflecting softer demand and competitive pressure, according to Charles & Colvard investor relations as of 02/13/2025. Management highlighted ongoing promotional activity in the broader lab?grown gemstone market as a headwind for pricing and margins.

Gross profit and operating margin are influenced by the mix between direct?to?consumer and wholesale channels, as online sales via the company’s own website generally carry higher margins than wholesale shipments to retail partners. Operating expenses are driven by marketing spend, technology investments in the web platform and fixed costs at the headquarters. The management team has been working on cost reductions to align expenses with current revenue levels.

Another important driver is the company’s inventory strategy. Because lab?grown gemstones can be produced with fewer supply constraints than mined stones, inventory risk can emerge if consumer demand falls short of expectations. Charles & Colvard has been managing down inventories to improve its cash position and working capital, according to commentary accompanying the quarterly results released on February 13, 2025, by Charles & Colvard investor relations as of 02/13/2025.

Strategic review, delisting and capital structure

A key development for the stock was the company’s decision to delist from the Nasdaq Capital Market and move to the over?the?counter market. Charles & Colvard announced on December 20, 2024 that it would voluntarily delist its common stock from Nasdaq and deregister under the Securities Exchange Act of 1934, citing the costs and regulatory burdens associated with a national exchange listing, according to Charles & Colvard investor relations as of 12/20/2024.

The company explained that the delisting was expected to reduce expenses related to listing fees, compliance, legal and accounting services. Management indicated that these savings could be redirected toward operations and strategic initiatives. However, the move also means that the stock may now see lower liquidity and less visibility among institutional investors, as many mandates and trading systems are focused on major exchanges.

Alongside the delisting decision, Charles & Colvard disclosed that its board of directors had initiated a review of strategic alternatives. This process, announced on December 20, 2024, includes evaluating options such as a potential sale of the company, business combinations, financing transactions or other strategic steps, without a defined timetable, according to Charles & Colvard investor relations as of 12/20/2024. The outcome of such a review can have a material impact on existing shareholders, depending on whether a transaction emerges.

From a capital structure perspective, Charles & Colvard has historically carried limited financial debt, relying largely on equity and internal cash generation to fund operations. In the fiscal 2025 second?quarter update published on February 13, 2025, management pointed to cash and equivalents on hand and noted efforts to conserve liquidity through cost controls and inventory management, according to Charles & Colvard investor relations as of 02/13/2025. The company’s future financing options may also be influenced by its status as an over?the?counter?traded stock.

Industry trends and competitive position

The lab?grown gemstone industry has experienced strong growth over the past decade, driven by advances in production technology and changing consumer attitudes toward mined diamonds. In the US market, lab?grown diamonds and alternative stones have gained share in the bridal segment, appealing to price?conscious and sustainability?minded consumers. This backdrop is relevant for Charles & Colvard, which has long marketed moissanite as a high?sparkle alternative.

However, the same dynamics have also intensified competition. The number of brands and retailers offering lab?grown stones has increased, pushing companies to differentiate through design, branding and customer experience rather than rarity. Online?only jewelers and large marketplaces compete on price and marketing reach. For Charles & Colvard, maintaining brand recognition and justifying its value proposition are central competitive challenges in this environment.

Macro?economic conditions in the United States also influence the company’s prospects. Periods of higher interest rates and economic uncertainty can weigh on discretionary spending, including jewelry purchases. Conversely, improvements in consumer confidence can support demand for engagement rings and fashion pieces. The US remains the core market, but online channels give the company some reach into international customers, albeit from a smaller base.

Why Charles & Colvard matters for US investors

For US investors, Charles & Colvard represents an example of a niche consumer brand navigating a rapidly evolving retail landscape. The company is exposed to secular trends such as the growth of e?commerce, rising interest in lab?grown gemstones and shifting attitudes toward sustainability. Its performance can provide insights into how smaller specialty retailers adapt to competition from both traditional jewelers and digital?first entrants.

The stock’s migration from Nasdaq to the over?the?counter market may affect which investors follow it closely, but the underlying business remains focused on the US consumer. Changes in disposable income, wedding trends and online shopping habits all shape its revenue trajectory. For market participants studying small?cap and micro?cap consumer stocks, Charles & Colvard’s strategic review and cost?cutting efforts offer a case study in how management teams respond when growth slows and financing conditions tighten.

Conclusion

Charles & Colvard is navigating a period of transition characterized by a strategic review, cost optimization and a move from Nasdaq to the over?the?counter market. The latest quarterly update for the period ended December 31, 2024 shows that the company faces revenue headwinds and competitive pressure, but it is also working to manage expenses and preserve liquidity. For observers of the US lab?grown gemstone and jewelry sector, the company’s next steps—whether remaining independent, pursuing a transaction or reshaping its product mix—will be important to watch, as they may influence both its financial profile and its position in a crowded market.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.